Annual FCF
-$12.85 M
-$846.70 K-7.05%
December 31, 2023
Summary
- As of February 7, 2025, KTTA annual free cash flow is -$12.85 million, with the most recent change of -$846.70 thousand (-7.05%) on December 31, 2023.
- KTTA annual FCF is now -302.07% below its all-time high of -$3.20 million, reached on December 31, 2021.
Performance
KTTA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$3.12 M
+$918.40 K+22.74%
September 30, 2024
Summary
- As of February 7, 2025, KTTA quarterly free cash flow is -$3.12 million, with the most recent change of +$918.40 thousand (+22.74%) on September 30, 2024.
- Over the past year, KTTA quarterly FCF has increased by +$918.40 thousand (+22.74%).
- KTTA quarterly FCF is now -717.31% below its all-time high of -$381.80 thousand, reached on March 31, 2021.
Performance
KTTA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$14.18 M
+$105.90 K+0.74%
September 30, 2024
Summary
- As of February 7, 2025, KTTA TTM free cash flow is -$14.18 million, with the most recent change of +$105.90 thousand (+0.74%) on September 30, 2024.
- Over the past year, KTTA TTM FCF has increased by +$105.90 thousand (+0.74%).
- KTTA TTM FCF is now -3614.09% below its all-time high of -$381.80 thousand, reached on March 31, 2021.
Performance
KTTA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
KTTA Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.0% | +22.7% | +0.7% |
| 3 y3 years | - | +26.2% | -35.3% |
| 5 y5 years | - | +26.2% | -35.3% |
KTTA Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -302.1% | at low | -77.6% | +27.8% | -343.8% | +1.7% |
| 5 y | 5-year | -302.1% | at low | -717.3% | +27.8% | -3614.1% | +1.7% |
| alltime | all time | -302.1% | at low | -717.3% | +27.8% | -3614.1% | +1.7% |
Pasithea Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.12 M(-22.7%) | -$14.18 M(-0.7%) |
| Jun 2024 | - | -$4.04 M(-6.5%) | -$14.29 M(+4.1%) |
| Mar 2024 | - | -$4.32 M(+60.0%) | -$13.73 M(+6.9%) |
| Dec 2023 | -$12.85 M(+7.1%) | -$2.70 M(-16.3%) | -$12.85 M(-4.3%) |
| Sep 2023 | - | -$3.23 M(-7.4%) | -$13.43 M(-6.9%) |
| Jun 2023 | - | -$3.48 M(+1.2%) | -$14.43 M(+12.0%) |
| Mar 2023 | - | -$3.44 M(+4.9%) | -$12.88 M(+7.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$12.00 M(+275.6%) | -$3.28 M(-22.4%) | -$12.00 M(+14.5%) |
| Sep 2022 | - | -$4.23 M(+118.8%) | -$10.48 M(+53.9%) |
| Jun 2022 | - | -$1.93 M(-24.7%) | -$6.81 M(+26.6%) |
| Mar 2022 | - | -$2.57 M(+46.0%) | -$5.38 M(+68.3%) |
| Dec 2021 | -$3.20 M | -$1.76 M(+215.5%) | -$3.20 M(+122.2%) |
| Sep 2021 | - | -$557.00 K(+11.5%) | -$1.44 M(+63.2%) |
| Jun 2021 | - | -$499.40 K(+30.8%) | -$881.20 K(+130.8%) |
| Mar 2021 | - | -$381.80 K | -$381.80 K |
FAQ
- What is Pasithea Therapeutics annual free cash flow?
- What is the all time high annual FCF for Pasithea Therapeutics?
- What is Pasithea Therapeutics annual FCF year-on-year change?
- What is Pasithea Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Pasithea Therapeutics?
- What is Pasithea Therapeutics quarterly FCF year-on-year change?
- What is Pasithea Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Pasithea Therapeutics?
- What is Pasithea Therapeutics TTM FCF year-on-year change?
What is Pasithea Therapeutics annual free cash flow?
The current annual FCF of KTTA is -$12.85 M
What is the all time high annual FCF for Pasithea Therapeutics?
Pasithea Therapeutics all-time high annual free cash flow is -$3.20 M
What is Pasithea Therapeutics annual FCF year-on-year change?
Over the past year, KTTA annual free cash flow has changed by -$846.70 K (-7.05%)
What is Pasithea Therapeutics quarterly free cash flow?
The current quarterly FCF of KTTA is -$3.12 M
What is the all time high quarterly FCF for Pasithea Therapeutics?
Pasithea Therapeutics all-time high quarterly free cash flow is -$381.80 K
What is Pasithea Therapeutics quarterly FCF year-on-year change?
Over the past year, KTTA quarterly free cash flow has changed by +$918.40 K (+22.74%)
What is Pasithea Therapeutics TTM free cash flow?
The current TTM FCF of KTTA is -$14.18 M
What is the all time high TTM FCF for Pasithea Therapeutics?
Pasithea Therapeutics all-time high TTM free cash flow is -$381.80 K
What is Pasithea Therapeutics TTM FCF year-on-year change?
Over the past year, KTTA TTM free cash flow has changed by +$105.90 K (+0.74%)